Brexpiprazole, a Serotonin-Dopamine Activity Modulator, Can Sensitize Glioma Stem Cells to Osimertinib, a Third-Generation EGFR-TKI, via Survivin Reduction
Shuhei Suzuki(Yamagata University), Masashi Okada(Yamagata University)
Cited by 42
Related Papers
Targeting the K-Ras - JNK axis eliminates cancer stem-like cells and prevents pancreatic tumor formation
|Oncotarget|2014|74
The novel JNK inhibitor AS602801 inhibits cancer stem cells <i>in vitro</i> and <i>in vivo</i>
|Oncotarget|2016|59
JNK contributes to temozolomide resistance of stem-like glioblastoma cells via regulation of MGMT expression
|International Journal of Oncology|2013|54